M&A Volume May Shift From Hospice to Home Health
Hospice News
MARCH 26, 2024
Though many expect a hospice M&A rebound in 2024, the scales are tipping in favor of home health companies among buyers. After 2023’s slump, PE firms have been sitting on more than $800 million in dry powder, according to data shared with Hospice News by The Braff Group. Interest rates remain a wild card.
Let's personalize your content